At EULAR 2012, the Annual European Congress of Rheumatology in Berlin join us at the GE Healthcare / Abbott co-sponsored TUI Satellite Symposium: "Treat to target: What are the benefits of using a targeted ultrasound approach?"
According to the symposium chairman Paul Emery, Arthritis Research UK Professor of Rheumatology, "Treat to Target (T2T) has revolutionised the management of rheumatoid arthritis (RA), making clinical remission a realistic goal for many patients. Imaging modalities are critical for the early diagnosis and monitoring of RA. Application of tools such as sonography in conjunction with T2T principles may further improve clinical outcomes"
Few words about TUI initiative:
Targeted Ultrasound Initiative (TUI) is an international effort led by a world-leading faculty of rheumatologists and ultrasound leads (18 experts from UK, France, Italy, Spain, Germany, Denmark, Japan, Hungary) to help increase the expertise of ultrasonography amongst a network of rheumatologists. TUI also aims to create a network of researchers to undertake multinational research to answer critical questions in the application of ultrasound to clinical practice. http://www.targetedultrasound.net/
Comments